Compounds > n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine
Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Constriction, Pathologic

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Constriction, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cottrill, CM; Coupal, JJ; Kung, HF; O'Connor, W; Ryo, UY; Shih, WJ1

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Constriction, Pathologic

ArticleYear
Iodine-123-HIPDM lung imaging in pulmonary vein-banded pulmonary hypertension.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1990, Volume: 31, Issue:5

    Topics: Animals; Constriction, Pathologic; Hypertension, Pulmonary; Iodine Radioisotopes; Iodobenzenes; Lung; Male; Pulmonary Veins; Radionuclide Imaging; Rats; Rats, Inbred Strains

1990